This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Steven Brian Gendreau
Introduction
Steven Brian Gendreau is a notable inventor based in Belmont, California. He has made significant contributions to the field of cancer treatment, particularly in the area of breast cancer therapies. His work focuses on innovative methods that enhance the effectiveness of existing treatments.
Latest Patents
Gendreau holds a patent for "Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib." This patent outlines methods and compositions for treating breast cancer in patients using a PI3K inhibitor, GDC-0941, in combination with an endocrine therapy agent. This innovative approach aims to improve treatment outcomes for patients suffering from this specific type of breast cancer.
Career Highlights
Steven Brian Gendreau is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Gendreau has collaborated with esteemed colleagues, including Mika K Derynck and Lori Friedman. These collaborations have fostered a productive environment for research and innovation in cancer treatment.
Conclusion
Steven Brian Gendreau's contributions to cancer treatment through his innovative patent and work at Genentech highlight his commitment to improving patient outcomes. His research continues to pave the way for advancements in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile